Gastroesophageal reflux is common among asthmatics. It not only may wo
rsen during an episode of airways obstruction but also may serve as a
trigger for such an attack. Both animal and clinical data suggest that
gastroesophageal reflux serves as a trigger of bronchospasm, potentia
tes the bronchomotor response to additional triggers, or both. Patient
s with reflux-associated asthma may manifest symptoms of gastroesophag
eal reflux, either classic or atypical, but approximately 25% to 30% h
ave clinically silent reflux. Despite the use of inadequate doses of a
cid-suppressive medicines, clinical trials have documented improvement
in respiratory symptoms among asthmatics following the treatment of r
eflux. Recent trials suggest long-term improvement in respiratory symp
toms following antireflux surgery. Selected patients with asthma shoul
d be evaluated for gastroesophageal reflux. If it is present, such pat
ients may benefit from aggressive antireflux therapy.